Sept 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment ...

An organic catalyst offers chemists precise control over a vital step in activating hydrocarbons. Researchers have developed ...

The Company was founded on January 27, 1975, and is headquartered in Osaka, Japan. About Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., (Nasdaq: CPRX) is a biopharmaceutical company ...

Japan logged a current account surplus of 38 trillion yen about 257 billion US dollars in August the highest on record for the month as the dep ...

QUVIVIQ™ is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep ...

JCR announced that it will present preclinical data in a poster session at the European Society of Gene and Cell Therapy ...